Findings from the 4th Copenhagen City Heart Study [24] and the Tromsø Study [25] indicated that elevated levels of circulating OPG were predictive of increased risk for ischemic heart disease, ischemic stroke, and all-cause mortality in general population. This evidence concerns the gene TNFRSF11B and ischemic stroke.